Company intelligence / Profile preview

PhenoVista Biosciences

San Diego, California, United Statesphenovista.com ↗

Ownership: Private
Development stage: Other

Overview

PhenoVista is a leading CRO specializing in high-content imaging-based phenotypic assays and custom cell-based in vitro models. The company enables biopharma clients to de-risk R&D decisions by providing actionable data on lead optimization, mechanism-of-action studies, target validation and more—primarily supporting preclinical research across neurobiology/CNS disorders and oncology/immuno-oncology. It does not have its own clinical pipeline or results.

Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapy
Industry: Drug Discovery Services

Partnerships

NETRI (partnership to expand organ-on-chip service offerings for drug development)Collaborates with over 200 biopharmaceutical companies globally as clients.

Beyond the preview

Go deeper on PhenoVista Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhenoVista Biosciences.

Explore the full profile